832TiPInfigratinib versus gemcitabine plus cisplatin...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

832TiPInfigratinib versus gemcitabine plus cisplatin multicenter, open-label, randomized, phase III study in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: The PROOF trial

Abou-Alfa, G K, Borbath, I, Clarke, S J, Hitre, E, Louvet, C, Macarulla, T, Oh, D-Y, Spratlin, J L, Valle, J W, Weiss, K H, Berman, C, Howland, M, Ye, Y, Cho, T, Moran, S, Javle, M M
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz247.158
Date:
October, 2019
File:
PDF, 85 KB
2019
Conversion to is in progress
Conversion to is failed